Gary Hingorani Email & Phone Number | Gary Hingorani has been with Pfizer Boulder since 2019 as the head of ADME (Absorption, Distribution, Metabolism, and Excretion). Gary brings more than 30 years of experience in pharmaceutical research, as well as in building and motivating highly efficient and productive teams. He provides ADME expertise to guide design of small molecule compounds in conjunction with medicinal chemistry leads in support of the oncology portfolio. His scientific leadership and enzymology knowledge drive scientific innovation relevant to the understanding of drug clearance, biotransformation/enzyme kinetics, tissue binding and disposition, reaction phenotyping, enzyme inhibition/induction or relevant DDI, and delivery or conduct of quality preliminary and definitive ADME studies in support of regulatory filings. As the ADME lead, he and his team offer guidance and expertise on drug interactions and human dose predictions from pre-FIH through transition to late development. He is a DMPK lead author for IND submissions and IB updates, having contributed to over 28 INDs and the subsequent approval of 8 NDAs. He thrives in environments where he can collaborate with other scientists and clinicians to create new biomedical advances that benefit patients. He has gained his DMPK expertise during the last 20 years under the direction of Dr. Ronald Franklin and Dr. Dylan Hartley.

Gary Hingorani

Gary Hingorani has been with Pfizer Boulder since 2019 as the head of ADME (Absorption, Distribution...
Boulder, Colorado, United States

*50 free lookup(s) per month.

Gary Hingorani’s Phone Numbers +1 303-938-****

Get GARY’s Phone Number (For Free)

Social Media

Gary Hingorani’s Location Boulder, Colorado, United States

Gary Hingorani’s Current Industry Pfizer

Gary Hingorani’s Prior Industry Array Biopharma | Amgen | Parke Davis

Find accurate emails & phone numbers for over 700M professionals.

Senior Director, ADME/DMPK

2021-10-01 00:00:00 - Present

Associate Director, DMPK

2018-01-01 00:00:00 - 2019-08-01 00:00:00

Research Associate III - Quantitative Biology

1996-01-01 00:00:00 - 1998-01-01 00:00:00

Senior Assistant Scientist - Cardiovascular Pharmacology

1988-01-01 00:00:00 - 1993-01-01 00:00:00

No Skills Available

No Languages Available

Gary Hingorani is a Gary Hingorani has been with Pfizer Boulder since 2019 as the head of ADME (Absorption, Distribution, Metabolism, and Excretion). Gary brings more than 30 years of experience in pharmaceutical research, as well as in building and motivating highly efficient and productive teams. He provides ADME expertise to guide design of small molecule compounds in conjunction with medicinal chemistry leads in support of the oncology portfolio. His scientific leadership and enzymology knowledge drive scientific innovation relevant to the understanding of drug clearance, biotransformation/enzyme kinetics, tissue binding and disposition, reaction phenotyping, enzyme inhibition/induction or relevant DDI, and delivery or conduct of quality preliminary and definitive ADME studies in support of regulatory filings. As the ADME lead, he and his team offer guidance and expertise on drug interactions and human dose predictions from pre-FIH through transition to late development. He is a DMPK lead author for IND submissions and IB updates, having contributed to over 28 INDs and the subsequent approval of 8 NDAs. He thrives in environments where he can collaborate with other scientists and clinicians to create new biomedical advances that benefit patients. He has gained his DMPK expertise during the last 20 years under the direction of Dr. Ronald Franklin and Dr. Dylan Hartley.